Cm-p5, a molluscan-derived antifungal peptide exerts its activity by a membrane surface covering in a non-penetrating

M Gonzalez-Garcia1, B Bertrand2, E M Martell-Huguet1

  • 1Centro de Estudios de Proteínas, Facultad de Biología, Universidad de La Habana, 25th st No 455, Vedado, Plaza, Havana 10400, Cuba.

Peptides
|November 3, 2024
PubMed

Insights

Antimicrobial peptide Cm-p5 shows fungistatic activity against Candida albicans. Biophysical studies indicate Cm-p5 does not disrupt fungal membranes, suggesting a non-pore-forming mechanism of action.

Area of Science:

  • Microbiology
  • Biophysics
  • Medicinal Chemistry

Background:

  • Antimicrobial Peptides (AMPs) are promising alternatives to antibiotics due to rising multi-resistant pathogens.
  • The antifungal peptide Cm-p5 exhibits fungistatic activity against Candida albicans, but its mechanism remains unclear.
  • Understanding AMP mechanisms is crucial for developing new antifungal therapies.

Purpose of the Study:

  • To elucidate the mechanism of action of the antifungal peptide Cm-p5 against Candida albicans.
  • To investigate the interaction of Cm-p5 with fungal lipid membranes using biophysical techniques.
  • To determine if Cm-p5 perturbs membrane stability, fluidity, or integrity.

Main Methods:

  • Liposome leakage assays to assess membrane stability.
  • Laurdan generalized polarization (GP) to measure membrane fluidity.
  • Fluorescent reporter assays (3,3'-dipropylthiadicarbocyanine iodide) to detect membrane depolarization.
  • Dynamic Light Scattering (DLS) to analyze liposome size changes.
  • Langmuir monolayer isotherms to study peptide-membrane interactions.
  • Molecular dynamics (MD) simulations to model peptide-membrane interactions.

Main Results:

  • Cm-p5 did not perturb lipid membranes or cause leakage, even at high concentrations.
  • No membrane depolarization was observed in Candida albicans cells or liposomes.
  • DLS and Langmuir isotherms indicated Cm-p5 slightly covers the membrane surface without significant insertion or rupture.
  • MD simulations corroborated in vitro findings, showing minimal interaction and perturbation of the fungal membrane model.
  • Results suggest Cm-p5 is not a pore-forming peptide.

Conclusions:

  • Cm-p5 does not exert its fungistatic effect by forming pores or significantly disrupting the fungal membrane.
  • Alternative mechanisms, such as nutrient limitation or receptor-mediated signaling, should be investigated for Cm-p5's mode of action.
  • Further research into non-pore-forming AMPs like Cm-p5 is warranted for novel antifungal drug development.